Published by Pinnacle Pulse, maker of a self-tracking app. We have no affiliate or sales relationship with any peptide seller. Editorial policy →

GHK-Cu: what the research shows, and what it doesn’t

By Pinnacle Pulse Editorial Team · Status as of 16 October 2026 · Next scheduled update: 14 January 2027

Short answer: GHK-Cu is a three-amino-acid peptide bound to copper, best known as a skin-care ingredient. Most of the research behind it comes from cell cultures, animal models and gene-expression analyses. A 2025 review of its use against wrinkles noted a “surprising absence of clinical studies”. For injected GHK-Cu, FDA cites limited human data.

What GHK-Cu is

GHK stands for glycyl-histidyl-lysine, three amino acids in a row. The peptide occurs naturally in human plasma and grabs copper ions readily, and the EU’s cosmetic ingredient database, CosIng, lists the copper-bound form as copper tripeptide-1.

In the EU and the US, GHK-Cu lives mostly in the cosmetics aisle. This affects how you should read the evidence. Cosmetics don’t need a regulator’s approval before sale, and the claims made for them rest on a much lower bar than a drug’s.

What has been studied

Cells and gene data

The most cited summary is a 2018 review in the International Journal of Molecular Sciences by Loren Pickart and Anna Margolina, both of whom list R&D Skin Biology, a company in Bellevue, Washington, as their affiliation. The review describes GHK as stimulating collagen and elastin production, supporting skin cells called fibroblasts, and influencing the activity of large numbers of genes. Much of the support comes from cell experiments and from gene-expression databases, where researchers check which genes go up or down when cells are exposed to a compound.

Gene-expression data are a useful way to generate hypotheses. They are a long way from showing that a cream changes what your skin looks like in six months.

Skin

A 2025 review in BioImpacts by Mortazavi and colleagues asked the more down-to-earth question: does GHK actually get to where it would need to act? Based on cell studies, the authors consider it a credible anti-wrinkle ingredient. But they also wrote that there is “a surprising absence of clinical studies” using GHK-Cu or its palmitoylated cousin, and they spent much of the paper on the formulation problem. GHK is water-loving and unstable, which is a bad combination for something that has to cross the skin’s outer barrier. The review discusses chemical modifications, penetration-enhancing peptides and microneedles as possible fixes, all of which are still research topics.

Injection

Some sellers market GHK-Cu for injection. That is a separate product category with a separate set of questions. In 2026 FDA removed injectable GHK-Cu from the compounding nomination process, citing possible immune reactions and limited human data. GHK-Cu for routes other than injection remains in FDA’s Category 1 for compounding pharmacies, and FDA has said it will consult its advisory committee on it before the end of February 2027.

What the research does not show

It does not show that GHK-Cu products reduce wrinkles or improve skin in people over time. The 2025 review is clear that clinical studies are missing.

Results from cells and gene databases do not establish what happens in living skin, let alone in other organs.

There is no published evidence on the safety or effects of injected GHK-Cu in humans that would answer FDA’s concerns.

The research also doesn’t settle how much of a topically applied peptide reaches the deeper layers of skin. That depends heavily on the formulation, and the formulation in a given jar is rarely disclosed in enough detail to judge.

In the EU, GHK-Cu is used as a cosmetic ingredient under the Cosmetics Regulation, and whether a product counts as a cosmetic or a medicine depends on its purpose and claims. In the US, FDA also draws that line by intended use. WADA’s list does not name GHK-Cu, but WADA’s notes to the 2027 List warn that a peptide not named there may still be prohibited. More detail is on our page GHK-Cu legal status.

FAQ

Is GHK-Cu a drug or a cosmetic?

It depends on how a product is presented and what it is for. In skin-care products it is used as a cosmetic ingredient. A product marketed to treat a disease or to change body function would be regulated as a drug, in the US and the EU alike.

Is there clinical evidence that GHK-Cu works on skin?

Very little. A 2025 review found the case rests mainly on cell studies and noted a surprising absence of clinical studies.

Has injected GHK-Cu been studied in people?

Not in published clinical trials. FDA removed injectable GHK-Cu from the compounding nomination process in 2026, citing limited human data and possible immune reactions.

Sources

  • Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PMID 29986520
  • Mortazavi SM, et al. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. BioImpacts. 2025;15:30071. PMID 39963574
  • FDA. Bulk drug substances nominated for use in compounding under section 503A: categories (status 2026). fda.gov/media/94155/download
  • FDA. Certain bulk drug substances for use in compounding that may present significant safety risks. fda.gov
  • FDA. Is it a cosmetic, a drug, or both? (Or is it soap?) fda.gov
  • European Commission. Cosmetics legislation, Regulation (EC) No 1223/2009. single-market-economy.ec.europa.eu
  • European Commission. CosIng cosmetic ingredient database, entry COPPER TRIPEPTIDE-1, checked 16 October 2026. ec.europa.eu
  • WADA. 2027 Prohibited List: summary of major modifications and explanatory notes (PDF), checked 16 October 2026. wada-ama.org

Facts last checked: 16 October 2026.

About this article

Written by: the Pinnacle Pulse Editorial Team, the people who make the Pinnacle Pulse app. We work only from primary sources such as regulators, legal texts, trial registries and PubMed, and we remove claims we can’t check against one.

This article has not been reviewed by a physician. It is general information, not medical advice.

Spotted an error? Our editorial policy explains how to report it and how we correct mistakes.

Change log

  • 16 October 2026: First published.

From the makers of this site: Pinnacle Pulse is a neutral tracking app. We don’t sell or recommend any substance. About Pinnacle Pulse

This article is for general information only. It is not medical advice and does not recommend the use of any substance. Decisions about medicines belong with a qualified healthcare professional.